Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Susvimo
Pharma
Roche's eye disease meds Vabysmo, Susvimo show extended efficacy
Roche showed positive long-term data for its eye disease treatments Susvimo and Vabysmo.
Kevin Dunleavy
Jul 18, 2024 11:37am
Roche to reintroduce eye implant Susvimo 2 years after recall
Jul 8, 2024 5:10pm
Vabysmo soars as Roche grows through COVID sales declines
Feb 1, 2024 11:36am
Roche touts Vabysmo toe-to-toe data against Eylea in RVO
Oct 27, 2022 10:55am
Roche has run into a problem with its new eye med Susvimo
Oct 18, 2022 9:40am
Roche's Susvimo struggles for traction with eye doctors
May 11, 2022 12:08pm
